Omni Health Announced Launch of Consumer Goods Division; New Division Anticipated Revenue of $7mln in 2018
12 Décembre 2017 - 1:05PM
InvestorsHub NewsWire
MIAMI, FL -- December 12, 2017 -- InvestorsHub NewsWire -- Omni
Health, Inc., (OTC: OMHE), a vertically integrated healthcare
company dedicated to the development of pharmaceutical, anti-aging
products, and biotech engineering, today announced the launch of
its newly-created Consumer Products division commencing with first
order from a major US catalog house.
Omni Health’s Consumer Goods Division will be operating via a
subsidiary, Celebrity Brands Inc. Celebrity Brands will bring an
entirely new reach to Omni Health’s operations with a new set of
investment priorities and a sharpened set of portfolio choices to
accelerate growth and performance. The company will also focus on
strengthening its portfolio by acquiring a number of consumer,
revenue-generating brands, and by creating a platform for future
acquisitions that scale the distribution of company’s existing
brands. The Company anticipates this new division to bring a gross
revenue of over $7mln in 2018 with a very high margin EBIDTA.
Celebrity Brands’ first wholesale order is from Amerimark Direct
for Celeb Cream – one of the Company’s innovative anti-aging
products. Amerimark Direct is one of US largest mail order and
direct marketing companies operating ten catalogs and seven
websites and specializing in cosmetics, diet and weight loss,
personal care products, and As Seen on TV products, among
others.
“Omni Health’s new strategic plan establishes a clear set of
investment priorities, and the ability to capitalize on company’s
four decades of exemplary healthcare by becoming a major force in
manufacturing and distributing high-margin anti-aging and CBD
consumer brands with the greatest potential for growth and value
creation,” said Andrey Soloviev, Omni Health Chief
Executive Officer. “We will drive growth acceleration through more
effective and scaled commercial operations, increased investment in
our brands and capabilities, and the delivery of bigger and better
innovation across a broader set of categories.”
With this exciting development, Omni Health intends to become a
first mainstream force in the development and introduction to
market of innovative CBD and anti-aging consumer products through
long-term retail partnerships, high-profile celebrity endorsements,
and cross branding.
Safe Harbor Statement
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking statements
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Any forward-looking statements contained herein are
based on current expectations, but are subject to a number of risks
and uncertainties. The factors that could cause actual future
results to differ materially from current expectations include, but
are not limited to, risks and uncertainties relating to the
Company's ability to develop, market and sell products based on its
technology; the expected benefits and efficacy of the Company's
products and technology; the availability of substantial additional
funding for the Company to continue its operations and to conduct
research and development, and future product commercialization; and
the Company's business, research, product development, regulatory
approval, marketing and distribution plans and strategies.
Contact:Andrey SolovievCEOceo@OmniHealth.md
Omni Health (CE) (USOTC:OMHE)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Omni Health (CE) (USOTC:OMHE)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024